June 12, 2026 a 07:43 pm
ABBV: Fundamental Ratio Analysis - AbbVie Inc.
AbbVie Inc. continues to present itself as a formidable player in the global biopharmaceutical landscape, leveraging its diverse therapeutic portfolio. Despite some financial challenges, its strategic focus and innovative pipeline ensure a robust competitive position in the market. Investors should weigh both the promise of innovation and the challenges of market competition and regulatory environments.
Fundamental Rating
AbbVie's fundamental analysis reveals a balanced profile, though certain financial ratios indicate potential concerns.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 1 | |
| Price to Book | 1 |
Historical Rating
Comparing past and present scores provides insight into AbbVie's financial trajectory.
| Date | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | 3 | 4 | 4 | 4 | 1 | 1 | 1 |
| Previous Date | 0 | 4 | 4 | 4 | 1 | 1 | 1 |
Analyst Price Targets
Analysts project a favorable pricing scenario, reflecting confidence in AbbVie's market potential.
| High | Low | Median | Consensus |
|---|---|---|---|
| $298 | $223 | $259 | $256.92 |
Analyst Sentiment
The majority of analysts maintain a lean towards buying, signaling confidence in AbbVie's future performance.
| Recommendation | Count | Representation |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 28 | |
| Hold | 12 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
AbbVie Inc.'s robust pharmaceutical pipeline and continual investment in research and development underpin its strong market positioning. While some financial indicators point to risks, notably in debt management, the overall analyst sentiment remains positive with a strong bias towards buying. This reflects the potential for future growth despite existing challenges. Investors should consider balancing these prospects with the inherent risks linked to innovation and industry competition.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years